A Handy Automation Tool Closes Programs at the Scheduled Time

a Windows schedule tool enables users to close running programs at a scheduled time

AutoClose Screenshot

a Windows schedule tool enables users to close running programs at a scheduled time

Logo of AutoClose Program

AutoClose is a new freeware utility that enables users to close running programs at the scheduled time automatically.

L.A., CALIFORNIA, US, October 11, 2018 /EINPresswire.com/ — AutoClose.net today releases the new handy freeware tool AutoClose, which allows users to specify how and when to close running programs on the Windows system if they need to be away from the computer. The file size of this tiny tool is only 1.3 MB (portable version is 1.0 MB), so users could easily download, store or share the program. With AutoClose users can also decide to shut down, log off, hibernate, reboot the computer or turn off the monitor after closing all specific programs. It can support multiple tasks at a time and enable to end background tasks effectively.

Sometimes people may put a file on rendering or when they are downloading a large file, or even when the system and applications are upgrading; there is no way to avoid leaving the computer on for hours. At times like these, the AutoClose application that automatically ends all activities and switches off the PC once completed all tasks would be very helpful.

AutoClose is not only designed to close programs and turn off the computer automatically, but it also gives users plenty of other options as well. Users can also indicate if they want to put the system to sleep or hibernate after a certain period. This function can allow users to resume working from where they left off. AutoClose gives them the power to decide when they want to reboot the computer as well. Once the specified time is up, AutoClose diligently follows all instructions. Moreover, users can use this program to simply turn off the monitor display if they do not want to end other running tasks. This feature can allow their applications to run in the background while keeping the system secure. AutoClose is particularly useful in workplaces where information security is crucial. If a user has to leave the desk while a program is running on the computer, AutoClose has the ability to turn off the monitor display to keep all data privately.


– Close Programs at a Specific Time
– Close Programs after a Period
– Close Hidden Processes
– Auto Shutdown/Hibernate/Reboot/Log Off
– Multiple Tasks / Batch Close
– Auto Turn off Display Monitor
– Portable Version
– Only 1.3 MB

Pricing and availability

AutoClose is free of cost. It works on Windows XP/Vista/7/8/10, Windows Server 2003/2008/2012/2016/2019 and later.


Website: https://AutoClose.net
Download (EXE Installer & Portable version): https://AutoClose.net/download.html

Olivia Cook
email us here
Visit us on social media:

AutoClose – A tiny tool closes programs on the scheduled time automatically

Source: EIN Presswire

Friday is World Arthritis Day 2018

MRI Test for Thomas at Great Ormond Street Childrens Hospital

MRI Test for Thomas at Great Ormond Street Childrens Hospital

Thomas in Great Ormond Street Childrens Hospital

Thomas recovering after treatment at Great Ormond Street Childrens Hospital

Doctor with Non-Invasive NBT Device by ANCON Medical

Doctor with Non-Invasive NBT Device by ANCON Medical

This Friday 12 October is World Arthritis Day, raising global awareness and understanding around life with Arthritis

The NBT device is versatile and promises to change the lives of children as yet undiagnosed with this painful disease in a non-invasive and much less intimidating way than current testing procedures.”

— Wesley Baker – CEO of ANCON Medical

CANTERBURY, KENT, UK, October 11, 2018 /EINPresswire.com/ — This Friday 12 October is World Arthritis Day, raising global awareness and understanding around life with rheumatic and musculoskeletal diseases and the importance of gaining early diagnosis and access to care.

The wide-ranging forms of arthritis, most specifically Juvenile Idiopathic Arthritis (JIA), are pathological conditions closely observed by the team at ANCON Medical after the diagnosis in 2017 of Thomas; the son of the company’s CEO, Wesley Baker. Since his diagnosis last year, Thomas has undergone several treatments at Kent and Canterbury Hospital and Great Ormond Street Children’s Hospital in London and is courageously fighting against worsening symptoms each day, and being treated by new breakthrough biologics drugs, chemotherapy and strong steroid treatment.

Early diagnosis of Arthritis is key to preventing further damage, but Arthritis often receive delayed or no diagnosis; reducing peoples' quality of life and affecting physical abilities. This is precisely the kind of disease where ANCON Medical’s advanced disease screening technology can be life-changing. Non-invasive, simple to use, and affordable, the ANCON’s Nanoparticle Biomarker Tagging (NBT) technology can detect the presence of disease by measuring exhaled breath for signs of the disease.

ANCON Medical also supports the campaign to raise awareness of the CCAA (Children’s Chronic Arthritis Association): a leading support charity in England and Wales for families with children suffering from Juvenile Idiopathic Arthritis (JIA). CCAA is run by people who have been affected by the disease and are passionate about supporting others and providing a support network for children with Arthritis and their families.

ANCON Medical’s life-changing NBT technology works by detecting breath specific “biomarkers,” which are DNA-protein controlled volatile organic compound (VOC) metabolites specific to diseases. Researchers have discovered biomarkers for more than 400 diseases, including lung, bowel and other cancers and are working to find those related to the various arthritic conditions faced by around 3 million people in Europe alone.

By using machine learning software in association with the NBT technology the device can hunt for these specific molecules, so that the disease can be diagnosed early, thereby increasing treatment options and survival probability. No technology on the market is as highly sensitive at detecting biomarkers as NBT, which can detect the fingerprints of the disease at concentrations as low as one ion in 10,000 cubic centimetres, giving the device a sensitivity that could be measured down to a single molecule.

“The NBT device is very versatile and promises to change the lives of children as yet undiagnosed with this painful disease in a non-invasive and much less intimidating way than current testing procedures. Although unfortunately too late for Thomas’s JIA diagnosis, it can also be used to screen for diseases such as cancer and potentially be reassigned to test for a range of other diseases when needed,” says Wesley Baker, who is a member of the Royal Society of Medicine.

For more information on ANCON Medical’s NBT technology research, visit www.anconmedical.com.

Further information:
JIA is a painful autoimmune disease, where your immune system gets confused and attacks healthy joint tissue, causing inflammation and at times severe damage it is a life-changing illness. There are an estimated 12,000 children and young people living with JIA in the UK, representing 1 child in every 1,000 under the age of 16. Early diagnosis is key to limiting the progression of this painful and potentially debilitating disease.

Visit http://www.anconmedical.com for more information on ANCON.
Visit https://www.ccaa.org.uk for more information on charity CCAA for JIA.
Visit https://www.jia.org.uk for information more general for JIA.

Joanna Stephens
Ancon Technologies & Ancon Medical
+44 1227 811705
email us here

Source: EIN Presswire

Merck Foundation plans to conduct 5th Edition of “Merck Africa Asia Luminary” in Dakar, Senegal

From (L-R) H.E. First Lady of the Republic of Chad Madame Hinda Deby Itno; H.E. First Lady of the Republic of Niger Madame Aissata Issoufou Mahamadou Prof. Frank Stangenberg-Haverkamp, Chairman of the Executive Board of E. Merck KG; ; H.E. First Lady of t

5th Edition of Merck Africa Asia Luminary

Merck Foundation plans to conduct 5th Edition of “Merck Africa Asia Luminary” in Dakar, Senegal

NAIROBI, KENYA, October 11, 2018 /EINPresswire.com/ — Merck Foundation, the philanthropic arm of Merck Germany plans to conduct 5th Edition of “Merck Africa Asia Luminary” under the patronage of The President of The Republic of Senegal, H.E. MACKY SALL and The First Lady of Senegal, H.E. MARIEME FAYE SALL, and in partnership with the Ministry of Health of Senegal.

Dr. Rasha Kelej, CEO of Merck Foundation emphasized, “Merck Foundation is very proud to welcome our guests of honor and keynote speakers, The First Ladies of 14 African Countries; H.E. First Lady of Benin, H.E. First Lady of Botswana, First Lady of Burkina Faso, H.E. First Lady of Burundi, H.E. First Lady of Central African Republic, H.E. First Lady of Chad, H.E. First Lady of Gambia, H.E. First Lady of Ghana, H.E. First Lady of Guinea –Bissau, H.E. First lady of Lesotho, H.E. First Lady of Niger, H.E. First lady of Sierra Leone and H.E. First Lady of Zambia. Together we will work on strong strategy to build healthcare capacity and provide the necessary training to establish a strong platform of experts in Diabetes, Hypertension, Cancer and Fertility care in their countries in collaboration with their offices and ministries of health.”
“During the conference, Merck Foundation will also celebrate two important occasions; the 350th Anniversary of Merck, the World’s Oldest Pharmaceutical & Chemical Company established in 1668 and the 1st Anniversary of Merck Foundation” Dr. Kelej added.

The President of The Republic of Senegal, H.E. MACKY SALL will deliver his address and closing remarks on the Day 2 of the conference.

The First Lady of Senegal, H.E. MARIEME FAYE SALL will deliver the keynote speech along with H.E. CLAUDINE TALON, The First Lady of Benin;
H.E. NEO JANE MASISI, The First Lady of Botswana;
H.E. SIKA BELLA KABORÉ, The First Lady of Burkina Faso;
H.E. DENISE NKURUNZIZA, The First Lady of the Republic of Burundi;
H.E. BRIGITTE TOUADERA, The First Lady of Central Africa Republic;
H.E. HINDA DEBY ITNO, The First Lady of Chad;
H.E. MADAME FATOUMATTA BAH-BARROW, The First Lady of The Gambia;
H.E. ROSA GOUDIABY VAZ, The First Lady of Guinea Bissau;
H.E. MAESAIAH THABANE, The First Lady of Lesotho;
H.E. FATIMA MAADA BIO, The First Lady of Sierra Leone;
H.E. ESTHER LUNGU, The First Lady of Zambia;

Two high level Ministerial panels will also take place.

The first high level Ministerial panel on “Building Fertility care capacity and breaking the Infertility Stigma in Africa and Asia” will involve Hon. Abdoulaye Diouf SARR, Minister of Health and Social Action, of Sénégal; Hon. Sarah Opendi, Minister of State for Health of Uganda; Hon. Dr. Chitalu Chilufya, Minister of Health, Republic of Zambia; Hon. Susan Shabangu, Minister of Social Development, South Africa; Hon. Dr. Rashid A. Aman; Deputy Minister of Health, Ministry of Health of Kenya; Dr. Wim Leereveld, Founder-Access to Medicine Foundation, Chairman Index Initiative building, World Benchmarking Alliance; Prof. Oladapo Ashiru, President of Africa Fertility Society; Prof. Joe Leigh Simpson, Past President of International Federation of Fertility Societies – IFFS; Dr. Kamini Rao, Chairperson of IIRRH, India; Prof. Dr. Satish Kumar Adiga, Professor & Head, Department of Clinical Embryology, Kasturba Medical College, Manipal Academy of Higher Education; Mr. Paolo Carli, Head of Middle East & Africa, Merck Biopharma; Dr. Rasha Kelej, Chief Executive Officer, Merck Foundation.
The second high level Ministerial panel on “The role of Merck Foundation together with Governments to improve access to equitable healthcare solutions in Africa” will involve Hon. Dr. Idi Illiassou Maïnassara, Minister of Public Health, of the Niger; Hon. Aziz Mahamat Saleh Ahmat, Minister of Public Health, of Chad; Hon. Dr. Pierre Somse, Minister of Health and Population, Central African Republic; Hon. Dr. Alpha Tejan Wurie, Minister of Health and Sanitation, of Sierra Leone; Hon. Dr. Thaddée NDIKUMANA, Minister of Health and Fight against Aids, of Burundi; Hon. Dr. Isatou Touray, Minister for Health and Social Welfare, of The Gambia; Hon. Julieta Kavetuna, Deputy Minister of Health and Social Services, of Namibia; Prof. Dr. Kailash Sharma, Dean: Academic Projects, Tata Memorial Centre, India; Prof. Dileep Mhaisekar, Vice Chancellor – Maharastra University of Health Sciences (MUHS) India; Prof. Abdel-Rahman Zekri, Vice Dean – National Cancer Institute, Cairo University; Dr. Rasha Kelej, Chief Executive Officer, Merck Foundation.
Countries participating include: Angola, Bangladesh, Benin, Botswana, Burkina Faso, Burundi, Cameroun, Canada, Central Africa Republic, Chad, Congo Brazzaville, Côte D'ivoire, D R of Congo, Egypt, Ethiopia, Gabon, Germany, Ghana, Guinea –Bissau, Guinea Conakry, India, Indonesia, Ireland, Israel, Italy, Kenya, Lesotho, Liberia, Malaysia, Mali, Mauritius, Mozambique, Namibia, Nepal, Netherland, Niger, Nigeria, Philippines, Russia, Rwanda, Senegal, Sierra Leone, Somalia, South Africa, Sri Lanka, Sudan, Tanzania, The Gambia, Togo, Tunisia, U.A.E, U.K, U.S.A, Uganda, Zambia, Zimbabwe.

About Merck Oncology Fellowship Program

The Merck Oncology Fellowship Program, a key initiative of Merck Cancer Access Program, focuses on building additional capacity through medical education and training.

The lack of financial means is not the only challenge in Africa and developing countries, but a scarcity of trained health care personnel capable to tackle the prevention, early diagnosis and management of cancer at all levels of the health care systems is even a bigger challenge.

Merck Oncology Fellowship Program focuses on building professional cancer care capacity with the aim to increase the limited number of oncologists in Africa and Developing countries. The program provides One-year fellowship program at Tata Memorial Centre – India, One and half-years Oncology Fellowship programs at University of Malaya – Malaysia, Two years Oncology Fellowship Program at University of Nairobi – Kenya and Two years Master degree in Medical Oncology at Cairo University – Egypt, in partnership with African Ministries of Health, Local Governments and Academia.

Launched in 2016, over 43 candidates from more than 17 African countries have rolled in the Merck Oncology Fellowship Program. The program will continue to build cancer care capability in African countries such as Botswana, Cameroon, CAR, Ethiopia, Gambia, Ghana, Guinea, Liberia, Mauritius, Namibia, Niger, Nigeria, Rwanda, Senegal.

Diana Mbaluka
Merck Foundation
email us here

Message from Dr. Rasha Kelej, CEO of Merck Foundation

Source: EIN Presswire

The Astronot Makes its Central Oregon Premiere at the Bend Film Festival on Sunday, October 14

Tim Cash, Far From Earth Films

The Astronot is an Oregon-made feature film drama set during the 1960’s space race, directed and co-produced by Bend, Oregon filmmaker Tim Cash.

Making this film sometimes felt like an impossible task but we made it to the end and I’m super proud of what we created with very little resources and support.”

— Tim Cash, Far From Earth Films (Director of The Astronot)

BEND, OR, USA, October 10, 2018 /EINPresswire.com/ — The Astronot, currently on the film festival circuit, is screening at the Bend Film Festival in Bend, OR. The feature film whose story unfolds in Central Oregon, screens at the Tower Theatre in Bend on Sunday, October 14 at 10:30 am. The film has already won dozens of awards worldwide and this is the premiere screening in its hometown.

The film, a drama set in the Bend area during the space race of the 1960’s, was written/scored/starring/co-produced by Pennan Brae (Vancouver, Canada) and directed/co-produced by Tim Cash (Bend, OR).

The film follows Daniel McKovsky, a young Oregonian who lost both his parents at a young age and whose only solace is his fascination with space travel and the cosmos beyond. One day at the age of 30, he meets outgoing postal worker, Sandy Allister who had just moved to Bend from Cape Canaveral. This new inclusion into his otherwise lonely existence forces Daniel to confront his darkest fears of loss and emptiness which shall lead him towards becoming, The Astronot.

The Astronot was filmed in & about Bend, La Pine & Fort Rock, Oregon, using local cast and crew, including Director Tim Cash of Far From Earth Films. Mr. Cash and actress Yuvia Storm will be participating in a Q & A at the film’s screening with regards to its making. "Making this film sometimes felt like an impossible task but we made it to the end and I’m super proud of what we created with very little resources and support", says Tim Cash, Director of The Astronot.

The Astronot has already won accolades at various international film festivals in the USA, UK & Europe including Best Feature Film, Screenplay & Score. Pennan Brae's upcoming album (also called, The Astronot), features 11 songs which serve as the film’s soundtrack. The first single, “Walk With Me” was already released to radio in the UK, Canada & Europe and received airplay on over 200 stations. The album was recorded at Blue Light Studio in Vancouver with producer Kaj Falch-Nielsen, with additional sessions taking place in Los Angeles with composer/producer Eric Alexandrakis, renowned drummer Steve Ferrone and INXS bassist Garry Gary Beers. The second single, ‘Crashland’ is currently airing on rock radio in Canada.

The Bend Film Festival, a celebration of independent film, runs from October 11 – 14 in Bend, OR. For information on tickets, visit the festival’s website at www.bendfilm.org. For more information on The Astronot please visit www.TheAstronot.com and it’s screening, please visit: https://bendfilm2018.eventive.org/schedule/5b919f7ee271e8001e3c36e6

Amanda Alexandrakis
Film Marketeers
email us here

The Astronot Official Trailer

Source: EIN Presswire

Meth Lab Cleanup is now offering the FIRST clandestine drug lab decontamination course online.

Entrepreneurs no longer have to pay expensive franchise fees and royalties to start their own meth lab cleanup business.

ATHOL, IDAHO, UNITED STATES, October 10, 2018 /EINPresswire.com/ — Meth Lab Cleanup Company – The Original, is now offering the FIRST clandestine drug lab assessment and decontamination course online. The course can be electronically proctored to establish authenticity to regulators and clients. Entrepreneurs no longer have to pay expensive franchise fees and royalties to start their own meth lab cleanup business.

Meth Lab Cleanup Company (MLCC) is proud to offer the most comprehensive online Clandestine Drug Lab Assessment & Decontamination training available. Our experienced instructors offer a current and technically sound understanding of both OSHA requirements and nationwide standards for clandestine drug lab testing and remediation. Meth Lab Cleanup’s training staff includes a registered professional industrial hygienist with a Master’s Degree in Hazardous Waste Management and instructors with over a decade of drug lab and occupational safety and health experience. The online course instructor, Joe Mazzuca, has over 14 years of experience in this industry. He is an accredited expert witness and is considered a leader in clandestine drug lab assessment and decontamination services, technology, and regulation. This course was video-graphed live, in a classroom, to retain authenticity. Great care has been given to maintain fluidity between the video and presentation slides. The course also offers an in-depth look at the equipment needed to provide service. Students have the option to have the course exam electronically proctored, by web cam, to offer validation to regulators and clients. You have 30 days to complete the course and may start and stop as needed. A business course tailored to this industry will soon be posted to help guide new business owners in startup requirements.
There is no need to pay expensive franchise fees and royalties.

In addition to the online training described, MLCC offers a variety of web based training for environmental remediation professionals. These offerings include 40 hour initial Hazardous Waste Operations (HAZWOPER) training, 8 hour HAZWOPER refresher training; 8 hour HAZWOPER Supervisor training; Hazard Communication (HAZCOM) training; OSHA Respirator Training; Confined Space Training and Asbestos Awareness Training. Meth Lab Cleanup also offers an online methamphetamine screening course tailored to home inspectors. The course is accredited by the American Home Inspectors Association (AHIA), the International Association of Certified Home Inspectors, (InterNACHI) and the National Home Inspector Association (NHIA). Visit https://methlabcleanup.co to sign up.

Meth Lab Cleanup Company also provides do-it-yourself meth residue test kits. The first, MethAssure®, is a meth residue test that is analyzed by an independent laboratory. This test is quantitative and will determine exactly how much methamphetamine residue is present on a surface within two days of receipt at the lab. The second test method, Accumeth®, is an onsite, semi-quantitative immunoassay test which is tailored towards clandestine drug lab technicians, law enforcement, real estate professionals, industrial hygienists, home inspectors, landlords, home buyers and renters, remediation professionals and regulators. The Accumeth® tests target the most recognized legal standards of 0.1 ug/100cm2 or 0.5 ug/100cm2. Accumeth® kits are nonhazardous and can be disposed of as household waste. In situations where extensive or routine testing is required, MLCC offers the Black Box Reader® to quantify and document the Accumeth® test results. The Black Box is an electronic monitoring device that reads Accumeth® test results and provides a direct numerical readout of the results in 15 seconds. It is battery operated and fits in the palm of your hand! To purchase visit: https://accumeth.biz.

Meth Lab Cleanup Company (MLCC) is a privately-owned company providing professional environmental services throughout the United States. The company, established in 2003, specializes in clandestine drug lab assessment, decontamination, consultation and training. If you have any questions, please use our contact form at https://methlabcleanup.co. Or call 208-683-1974.

Joseph Mazzuca
Meth Lab Cleanup Company

Joseph Mazzuca
Meth Lab Cleanup LLC
email us here

Source: EIN Presswire

ICare4Autism National Conference on Apprentice to Workforce Programs for High School Students with Special Abilities

, ICare4Autism

Dr. Joshua Weinstein, Founder & CEO, ICare4Autism

ICare4Autism’s National Conference 2018 in Washington D.C. US Capitol Visitor Center began today at 9:30am.

WASHINGTON DC, DISTRICT OF COLUMBIA, UNITED STATES, October 10, 2018 /EINPresswire.com/ — ICare4Autism’s National Conference 2018 in Washington D.C. US Capitol Visitor Center began today at 9:30am with Opening Remarks by CEO and Founder of ICare4Autism, Dr. Joshua Weinstein.

“Our ultimate goal is the high school graduation of each student with a general education degree, and the readiness skills needed to pursue higher education and/or a well-paying job that will enable them to live full and independent lives.”

The national conference will focus on initiating an Apprentice Training Program for High School Students with Special Abilities across all 50 states. Speakers will discuss the importance of including high school students with special abilities in apprenticeship programs prior to entering the workforce.

Conference speakers include: Julian Alvarez III, Commissioner Representing Labor of Texas Workforce; Jennifer Sheehy, Deputy Assistant Secretary (ODEP); acclaimed professor and educator Stephen Shore, Ed.D. Clinical Asst. Professor, R.S. Ammon School of Education at Adelphi University; Robert Naseef, Ph.D. (PA) of Alternative Choices; policy advisor Scott M. Robertson, Ph.D., U.S. Department of Labor (ODEP); Carol M. Schall, Ph.D. Asst. Professor School of Education, Virginia Commonwealth University; David Kearon, Director of Adult Services, Autism Speaks.

Dr. Joshua Weinstein went on to note that “In recognizing the numerous opportunities in the high growth technology sector and the unique skills that high school students including those with disabilities possess, all of which can lead to high level career opportunities. This comprehensive apprentice workforce program provides individuals (prior to leaving High School) with a personalized transition plan which, if needed, will also include an employment specialist, job coach, assistance with job searches, as well as on-the-job training and support services.”

ICare4Autism’s main goal is to increase awareness of what they are currently doing in the organization, generate ideas about how to strengthen the US workforce such as accepting that inclusion works, and to create pathways for HS students.

ICare4Autism’s website is a wonderful resource for upcoming events, such as conferences, workshops and educational articles on the topic of Autism. Be sure to visit www.icare4autism.org for more information.

About ICare4Autism
ICare4Autism serves as the lead global non-profit organization dedicated to improving the life of children and adults who live with autism. Founded in 2004 by Dr. Joshua Weinstein, ICare4Autism has established itself as the catalyst that drives collaborations among similar international institutions to discover the etiology of autism, search for biologic and environmental causes, and ultimately work toward better methods of detection and treatment. We connect researchers and practitioners through renowned conferences and workshops to discuss state-of-the-art findings and innovative treatment practices to best serve people with special abilities and their families. 

Anjola Toro
email us here
Visit us on social media:

Source: EIN Presswire

Concept Medical Inc. Raises $60mn from cardiologist, philanthropist and serial entrepreneur Dr. Kiran Patel

Concept Medical & Envision Scientific

Dr. Kiran Patel

Manish Doshi

SURAT, GUJARAT, INDIA, October 10, 2018 /EINPresswire.com/ — Concept Medical Inc. (CMI) has approached the FDA for an Investigational Device Exemption (IDE) for their Sirolimus-Coated Balloon (DCB). To support this process, they have raised $60mn (for an undisclosed valuation) from cardiologist and serial entrepreneur Dr. Kiran Patel (Tampa, Florida). An IDE allows the investigational device to be used in a clinical study to collect safety and effectiveness data.

The funds will also be utilised to augment clinical data and clinical registries to qualify for reimbursement in the European markets, where the Company has commercially launched the product.

CMI, headquartered in Florida, has a manufacturing subsidiary in India, by the name, Envision Scientific Pvt. Ltd. (ESPL), where all their products are made. A portion of the funds will also be utilised to bolster the manufacturing operations to meet the increasing demand for their products globally. Their global distribution and marketing network are operated from offices in India, Singapore, Netherlands and Brazil. ESPL also has an India-focused, marketing and distribution business.

The Companies (CMI and ESPL), which were established about 10 years ago, have developed innovative and disruptive platform technologies in drug-delivery systems to address the unmet medical needs in interventional cardiology. They have 96 patents granted (another 40 under process) around the world in major markets like USA, China, Japan, Europe, India, Australia and others.

They have, since, successfully commercialized globally, their first product, "Abluminus-DES coronary stent", using their proprietary drug delivery and coating systems. "MagicTouch-DEB" (sirolimus- coated balloon with application in coronary and peripheral artery disease), is commercially sold in many European countries including the UK and other countries like South Africa, Mexico, Malaysia, Indonesia, Singapore, MENA region.

Extended applications of "MagicTouch-DEB" in Renal transplant, Erectile dysfunction, and AVF/AVG for Renal dialysis patients are under on-going clinical trials.

CMI raised the funds from the family office of 'Dr. Kiran and Pallavi Patel'. With the fresh infusion of funds, both CMI and ESPL aim to bolster their operations in the existing and new markets.

Manish Doshi, Founder & Managing Director of the Company says, "We want to make a world of difference to the way medical devices companies operate globally. We are a young organisation and innovation runs in the soul of our entire organisation. This investment enables us in advancing our innovation platforms vigorously. Besides the investment, Dr. K brings a serious value-add with his vast experience which is synergistic."

Dr. Kiran Patel, a staunch supporter of innovative and disruptive medical technologies, says, "Cardiovascular diseases (CVDs) are the number 1 cause of death globally, representing 31% of all global death and it is increasing due to changes in lifestyle and increase in hypertension amongst the young and old. I am excited to be a part of CMI whose research & innovative technologies will meet a major unmet need in patients with diabetes and cardiovascular diseases. This venture enables me to contribute to the millions of hearts beating around the world."

A Board-Certified cardiologist, Dr. Patel completed his residency in Internal Medicine in New Jersey after obtaining a Medical degree from Gujarat University in India and internship in Africa. Dr. Patel studied under the British Educational System in Zambia and received a Diploma from Cambridge University in the United Kingdom. In 1982, he completed his fellowship in Cardiology from a Columbia University-affiliated program.
Dr. Patel subsequently entered the managed care industry and was the Chairman of WellCare of Florida till 2002. While at WellCare, he also helped in turning around a struggling HMO in New York and merging it with the Florida HMO to form WellCare Management Group (WMG). Eventually, WMG grew to 400,000 members, with over $1 billion in revenues.
Later, Dr. Patel focused on healthcare informatics, and was a Member of Advisory Board of BelHealth Investment Partners, LLC. He was, until recently, the Chairman and President of Freedom Health, Inc. and Optimum Healthcare Inc. The companies recorded $1.7 billion in revenues under his leadership.
Dr. Patel is the Founder and Chairman of the 'Drs. Kiran and Pallavi Patel Family Foundation', well known for their philanthropy efforts, globally.

Established in 2008, Concept Medical pursues innovation in medical devices with an emphasis on drug delivery platform technologies with strong emphasis on intellectual property. Envision Scientific Pvt. Ltd., a subsidiary of Concept Medical, provides the manufacturing platform for the products of the Companies.

Farhana Siddique
Concept Medical
email us here
Visit us on social media:

Source: EIN Presswire

From 1636 to Today,Inventor Michael Catania Is the Harvard Student That Created the Most Intellectual Property

CEO of  LSC International Trading LLC

Inventor Michael Catania is on pace to surpass Steve Jobs

LSC International Trading LLC

From 1636 to Today,Inventor Michael Catania Is The Harvard Student That Created the Most IP. The LSC International Trading CEO is a prolific inventor.

To me, it make 100% sense that a Harvard Extension School Student is the one that holds this particular record. Hard work is key, as Thomas Edison said.”

— Inventor, Michael Catania

PHILADELPHIA, PA, USA, October 10, 2018 /EINPresswire.com/ — Throughout Harvard's almost 400-year history, there is no other student or alumni from Harvard University that created and invented more intellectual property then Michael Catania, from Laurel Springs, New Jersey Michael. Think about it, that is a lot of important alumni. The CEO of LSC International Trading current has 327 registered designs in the UK. With no end in sight; Michael's ultimate goal is to create over 5,000 inventions and registered designs.

After graduating in the top 1% of his class, as an undergrad at the Rutgers School of Business and Rutgers Honors College; Michael returned to Rutgers to complete his MBA. He graduated in the top 1%, a second time, while at Rutgers, earning his MBA. Michael then learned about the Harvard Extension School, Harvard's School for working adults. After getting his through the three admission courses, Michael is well on his way on completing his Harvard Degree.

Michael believes hard work is key. "If the 1.3 million engineers in the labor force living in the Silicon Valley area , all created 327 original inventions like me, that would result in about 425 million new inventions. The US GPD would grow by at least 100,000%. Millions of new jobs! But it takes hard work and the right creative mindset,” said Catania. " Apple, Microsoft and Google would all go bankrupt in a week, if all the engineers invented for themselves, but the United States of America and humanity would be the big winners."

Catania continues to work with LSC International Trading to make the world a better place with creative designs of green energy prototypes. With no end in sight, the future looks bright. LSC International Trading LLC was founded in 2017 in New Jersey with the goal of being the largest green energy and consumer electronics ,industrial design company in the world.

Youtube Channel and LSC International Trading Website —

John Bradley
LSC International Trading LLC
email us here
Visit us on social media:

Design and Invention with Michael Catania

Source: EIN Presswire

The New Plastic Surgery Practice That You’ve Been Waiting For Welcome to Signature Plastic & Reconstructive Surgery

Dr. Melissa Marks from Signature Plastic & Reconstructive Surgery

Dr. Melissa Marks from Signature Plastic & Reconstructive Surgery

Signature Plastic & Reconstructive Surgery

Signature Plastic & Reconstructive Surgery brings back patient-focused care

Plastic Surgery is not like getting your hair done – it’s Surgery- and I feel it is a high honor when a patient chooses me to perform surgery on them.”

— Dr. Melissa Marks

PALM BEACH GARDENS, FLORIDA, USA, October 9, 2018 /EINPresswire.com/ — Signature Plastic & Reconstructive Surgery, PLLC has opened in Palm Beach Gardens, Florida and this Plastic Surgery practice has a treatment approach that you will want to be a part of. Headed by their Plastic & Reconstructive Surgeon Dr. Melissa Marks, Signature Plastic & Reconstructive Surgery, PLLC is bringing back the patient-focused care that has been lost over the years. Offering a boutique practice with personalized concierge style service by Dr. Marks, you will finally receive the attention from your Plastic Surgeon that you are looking for.

“Deciding to have a surgical procedure is an extremely difficult and anxiety provoking decision for anyone” says Dr. Marks, “I feel that it is important to get to know your Plastic Surgeon and spend as much time needed for you to feel comfortable prior to undergoing surgery.”

With the growing popularity of Plastic Surgery reality TV shows, Social Media, and even people performing Plastic Surgery that aren’t Plastic Surgeons, the reality of Surgery often gets minimized. It is important to Dr. Marks that her patients are fully informed, educated, and comfortable prior to their surgical experience.

“Plastic Surgery is not like getting your hair done – it’s Surgery- and I feel it is a high honor when a patient chooses me to perform surgery on them.”

Dr. Melissa Marks’ strong Surgical training and beliefs in patient-focused concierge style medicine is what sets Signature Plastic & Reconstructive Surgery apart from other Plastic Surgery practices in South Florida. Your experience will consist of nothing but personalized service and professionalism. Also, your one of a kind experience doesn’t end after your consultation. After your surgery, Dr. Melissa Marks will be available to you by cell phone 24 hours a day 7 days a week for questions, concerns, and office visits related to your procedure.

When compared to other Plastic Surgery practices in South Florida, Signature Plastic & Reconstructive Surgery is a smaller, boutique, Plastic Surgery practice. What this means is you will finally feel like YOU are getting the attention you deserve. Dr. Marks is proud to offer this environment without the usual fees associated with Concierge medicine.

In addition, Dr. Marks is affiliated with Palm Beach Gardens Medical Center, Jupiter Medical Center and Jupiter Outpatient Surgery Center.

To schedule a complimentary initial consultation with Dr. Melissa Marks at Signature Plastic & Reconstructive Surgery, call 561.775.1212, email info@drmelissamarks.com or visit the practice’s website at www.drmelissamarks.com.


About Signature Plastic & Reconstructive Surgery

With a patient-focused approach to plastic surgery, Signature Plastic & Reconstructive Surgery is changing the way people in the West Palm Beach area look on the outside and feel on the inside. Headed by Dr. Melissa Marks, the practice provides only the highest quality of personalized care and the most advanced techniques to restore one’s natural beauty. Men and women can dramatically benefit from the surgical procedures offered for the breast, body, face, neck, hand, arm and skin. Start with a free consultation with Dr. Marks today in our brand new office in Palm Beach Gardens to discuss your goals and learn why you deserve the Signature treatment.

Dr. Melissa Marks
Signature Plastic & Reconstructive Surgery
email us here
Visit us on social media:

Source: EIN Presswire

Leading U.S. Inventor and Priceline.com Founder Jay Walker to Speak at IPAS 2018

One of the most prolific U.S. inventors in history will join USPTO Director Iancu and IBM’s Manny Schecter at the IP Awareness Summit on November 29

The fact is that without a functioning licensing system we really don’t have what need to compete. Licensing is the way that inventions get into the economy.”

— Jay Walker, leading U.S. inventor; founder Priceline.com

NEW YORK, NY, USA, October 9, 2018 /EINPresswire.com/ — The Center for Intellectual Property Understanding (CIPU) announced today that that Jay Walker, Priceline.com founder and one of the most prolific and successful U.S. inventors, will be a featured speaker at the second annual Intellectual Property Awareness Summit in New York on November 29.

The Summit will take place at Columbia University’s famed Pulitzer Hall in the School of Journalism in conjunction with Columbia Technology Ventures. Registration is now open.

Mr. Walker, an owner of TEDMED, which bridges the gap between science and the public, has long held that the U.S. patent licensing system is broken and needs fixing.

“The fact is that without a functioning licensing system we really don’t have what need to compete,” Mr. Walker, a former member of the Forbes 400, has stated. “Licensing is the way that inventions get into the economy; it’s the way they get used and brought into the marketplace and creates jobs and helps our economy to be more competitive.”

Mr. Walker is number eight on the U.S. all-time U.S. inventor list with 950 issued utility patents. Thomas Edison had 1,084. At the current pace, Walker will surpass Edison sometime in 2023. Many of his patents cover gaming and risk calculation.

Joining Mr. Walker as an IPAS 2018 featured speaker is USPTO Director Andrei Iancu, who will present at 1:30 and is likely to touch upon U.S. and China IP issues. Another featured speaker is Manny Schecter, Chief Patent Counsel of IBM, who will speak about the impact IP in a digital world.

Other speakers and panelists include a range of IP thought-leaders, owners, educators and organizations. They will present and serve on panels. Breakout sessions focusing on specific IP leadership opportunities will take place at lunch. Registration for IPAS 2018 is open to the public but space is limited.

The IPAS theme is IP Literacy in a Digital World. The Summit will examine the impact of information and speed on how intellectual property is seen and often taken for granted, as well as ways to address it through education and the media.

To register, use the link in the second paragraph. To view the IPAS 2018 program and event website, visit www.ipawarenesssummit.com.

The current list of IPAS 2018 participants and partners can be found on the home page. Registration is free except for a small fee to cover food and overhead. Persons who wish to apply for a discounted or free admission, please contact explore@understandingip.org.

About the Center for IP Understanding

The Center for Intellectual Property Understanding is an independent, non-profit organization dedicated to increasing awareness of IP rights and their impact on people’s lives. CIPU provides information, conducts research and facilitates activities that seek to make IP more intelligible, enhance value and deter theft. The Center also tracks attitudes toward IP rights, including patents, copyrights, and trademarks, and through outreach, provides an education framework for understanding how IP promotes competition and creates jobs. To learn more, please visit www.understandingip.org.

Bruce Berman
Center for IP Understanding
email us here

Source: EIN Presswire